Novavax Inc (NASDAQ:NVAX)

10.88
Delayed Data
As of Jul 02
 -0.12 / -1.09%
Today’s Change
3.92
Today|||52-Week Range
11.45
+83.47%
Year-to-Date

Today’s Trading

Previous close11.00
Today’s open11.04
Day’s range10.77 - 11.07
Volume2,086,217
Average volume (3 months)3,281,260
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-14.82%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book11.32

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...-0.40-1.78%
KITEKite Pharma Inc+1.57+2.47%
RDUSRadius Health Inc+0.99+1.48%
CTLTCatalent Inc-0.10-0.34%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers